
Over the past two decades, zzso drugs zzso and, zzso the less toxic analogue zzso have zzso significant therapeutic benefit to a large number of cancer zzso However, there remains scope for substantial improvement in the clinical utility of metal coordination complexes through the discovery of additional zzso complexes (or possibly alternative zzso Future drug discovery strategies should focus on tumor resistance and its zzso To date, only one series of compounds, those containing a zzso carrier zzso zzso zzso zzso has entered clinical trial based on their zzso of acquired zzso resistance in some zzso zzso zzso tumor zzso At present these agents are in early clinical trial and thus their true clinical utility in zzso zzso disease is not yet zzso (and may not be due to zzso zzso Over the past few years, our understanding of mechanisms of resistance to zzso and its interaction with DNA has vastly zzso This new information will undoubtedly guide the development of new strategies aimed at the zzso of intrinsic and acquired tumor resistance to zzso zzso to circumvent resistance will probably involve not only the rational development of a new generation of zzso drugs zzso compounds designed to overcome reduced zzso zzso or enhanced removal of zzso DNA zzso but also zzso drugs which are capable of modulating resistance zzso zzso of signal zzso zzso zzso and zzso zzso expression and zzso zzso One may look forward with a great deal of optimism that these promising new approaches will result in clinical benefit by the end of the zzso Nevertheless, zzso and zzso remain the standard zzso drugs to which novel zzso complexes must be zzso 

